Development of lead compounds for trypanocidal drugs based on inhibitors targeted against parasite glycolysis

Projektinformationen

QUINONES WILFREDO

ID Finanzhilfevereinbarung: ICB1-CT-2001-80008

Projekt abgeschlossen

Startdatum 1 Juni 2000

Enddatum 30 November 2000

Finanziert unter

• Programme for research, technological development and demonstration on "Confirming the international role of Community research,1998-2002"

Gesamtkosten € 31 200,00

EU-Beitrag € 31 200,00

Koordiniert durch

CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY
Belgium

Ziel

Cloning, over-expression of one gene of interest of Leishmania Mexican and validation as drug target (PGAM, FR).General training in Molecular Biology and work in the corresponding INCO project

Wissenschaftliches Gebiet

• natural sciences › biological sciences › molecular biology

Programm/Programme

• FP5-INCO 2 - Programme for research, technological development and demonstration on "Confirming the international role of Community research,1998-2002"

Thema/Themen

• 1.2.1.-2. - Training for researchers

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY

• EU-Beitrag: Keine Daten
• Adresse: 74,Avenue Hippocrate 74, ICP-TROP 74.39 ; 1200 BRUXELLES ; Belgien
• Gesamtkosten: Keine Daten